Evidence map›Paper›PMID 30451912›Full record

ArticleScientific reports2018

Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity mice.

Misa Nakamura, Sachiko Nomura, Tadashi Yamakawa, Ryohei Kono, Akihiro Maeno, Takashi Ozaki, Akitoshi Ito, Toyonobu Uzawa, Hirotoshi Utsunomiya, Kennichi Kakudo

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. [Liver-bone axis: novel mechanisms and strategies for MAFLD regulation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  3. Article
  4. Review
  5. Mediators of Amylin Action in Metabolic Control.Journal of clinical medicine · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. An Analysis of the Anti-Neuropathic Effects of Qi She Pill Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Misa NakamuraDepartment of Rehabilitation, Osaka Kawasaki Rehabilitation University, 158 Mizuma, Kaizuka, Osaka, 597-0104, Japan. nakamuram@kawasakigakuen.ac.jp.
Sachiko NomuraDepartment of Strategic Surveillance for Functional Food and Comprehensive Traditional Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, 641-8509, Japan.
Tadashi YamakawaDepartment of Endocrinology and Diabetes, Yokohama City University Medical Center, 4-57 Urafunecho, Minamiku, Yokohama, 232-0024, Japan.
Ryohei KonoDepartment of Strategic Surveillance for Functional Food and Comprehensive Traditional Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, 641-8509, Japan.
Akihiro MaenoDepartment of Medical Chemistry, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka, 573-1010, Japan.
Takashi OzakiClinical Laboratory Department, Kinan Hospital, 46-70 Shinjo-cho, Tanabe, Wakayama, 646-8588, Japan.
Akitoshi ItoLaboratory for Pharmacology, Pharmaceuticals Research Center, Asahi Kasei Pharma Co. Ltd, 632-1 Mifuku, Izunokuni, Shizuoka, 410-2321, Japan.
Toyonobu UzawaMedical Affairs Department, Asahi Kasei Pharma Co. Ltd, 1-1-2 Yurakucho, Chiyoda-ku, Tokyo, 100-0006, Japan.
Hirotoshi UtsunomiyaDepartment of Strategic Surveillance for Functional Food and Comprehensive Traditional Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama, Wakayama, 641-8509, Japan.
Kennichi KakudoDepartment of Pathology, Nara Hospital, Kindai University Faculty of Medicine, 1248-1 Otoda-cho, Ikoma, Nara, 630-0293, Japan.
Wakayama Medical University · JPAsahi Kasei (Japan) · JPKansai Medical University · JPKinan Hospital · JPKindai University · JPOsaka Kawasaki Rehabilitation University · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcitonin (CT) plays an important role in calcium homeostasis, and its precursor, proCT, is positively associated with the body mass index in the general human population. However, the physiological role of endogenous CT in the regulation of metabolism remains unclear. Knockout mice with gene-targeted deletion of exon 4 of Calca (CT KO) were generated by targeted modification in embryonic stem cells. Male mice were used in all experiments and were fed a slightly higher fat diet than the standard diet. The CT KO mice did not exhibit any abnormal findings in appearance, but exhibited weight loss from 15 months old, i.e., significantly decreased liver, adipose tissue, and kidney weights, compared with wild-type control mice. Furthermore, CT KO mice exhibited significantly decreased fat contents in the liver, lipid droplets in adipose tissues, serum glucose, and lipid levels, and significantly increased insulin sensitivity and serum adiponectin levels. CT significantly promoted 3T3-L1 adipocyte differentiation and suppressed adiponectin release. These results suggested that CT gene deletion prevents obesity, hyperglycemia, and hyperlipidemia in aged male mice. This is the first definitive evidence that CT may contribute to glucose and lipid metabolism in aged male mice, possibly via decreased adiponectin secretion from adipocytes.

Indexed as

AdiponectinAdipose TissueAnimalsBody CompositionCalcitoninCalcitonin Gene-Related PeptideDiet, High-FatFemaleGlucoseInsulin ResistanceLipidsLiverMaleMiceMice, Inbred C57BLMice, KnockoutAdiponectinAdipoq protein, mouseCalca protein, mouseCalcitoninCalcitonin Gene-Related PeptideGlucoseLipids

Identifiers

PMID30451912
PMCPMC6242993
OpenAlexW2901896934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.